Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Central nervous system inflamed tissue" refers to regions within the brain or spinal cord affected by inflammation, evidenced by infiltration of immune cells (e.g., T cells, B cells, microglia, macrophages), cytokine secretion, and tissue injury. It is a pathological state present in multiple diseases such as multiple sclerosis, trauma, stroke, or neurodegeneration. Its molecular makeup is heterogeneous, with various cells and molecules contributing to the inflammatory process and tissue damage.
Mechanisms involve inhibition of components of the inflammatory cascade (e.g., cytokine blockade, inflammasome inhibition), not the tissue as a whole
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Central nervous system inflamed tissue.